GESSI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 17.714
EU - Europa 6.481
AS - Asia 3.613
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
AF - Africa 3
Totale 27.839
Nazione #
US - Stati Uniti d'America 17.696
CN - Cina 2.076
IT - Italia 2.008
UA - Ucraina 1.406
DE - Germania 1.222
TR - Turchia 1.007
GB - Regno Unito 525
SE - Svezia 440
SG - Singapore 365
FI - Finlandia 316
PL - Polonia 174
RU - Federazione Russa 150
FR - Francia 107
HK - Hong Kong 71
BE - Belgio 31
CZ - Repubblica Ceca 27
NL - Olanda 27
ID - Indonesia 26
ES - Italia 18
VN - Vietnam 15
CA - Canada 14
IR - Iran 13
IN - India 12
EU - Europa 7
AU - Australia 6
CL - Cile 6
JP - Giappone 6
RO - Romania 5
AT - Austria 4
CH - Svizzera 4
MX - Messico 4
DZ - Algeria 3
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
KR - Corea 3
MY - Malesia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
BR - Brasile 2
IE - Irlanda 2
IM - Isola di Man 2
IQ - Iraq 2
SA - Arabia Saudita 2
SI - Slovenia 2
UZ - Uzbekistan 2
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
EC - Ecuador 1
GR - Grecia 1
ME - Montenegro 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TH - Thailandia 1
Totale 27.839
Città #
Woodbridge 2.407
Fairfield 2.035
Jacksonville 1.584
Chandler 1.580
Houston 1.466
Ann Arbor 1.187
Ashburn 1.040
Wilmington 861
Seattle 820
Cambridge 670
Izmir 516
Nanjing 488
Beijing 399
Princeton 361
Boardman 290
Ferrara 273
Milan 261
Singapore 210
Shanghai 183
San Diego 171
Nanchang 165
Warsaw 154
Shenyang 151
Dearborn 149
Addison 111
Bremen 104
Hebei 98
Tianjin 95
Changsha 93
New York 93
Jiaxing 72
Hong Kong 70
Rome 61
San Mateo 60
Jinan 57
Norwalk 55
Mountain View 51
Zhengzhou 47
Florence 46
Kunming 46
Falls Church 43
Los Angeles 40
Orange 36
Auburn Hills 35
Düsseldorf 35
Redwood City 35
Ningbo 31
Brussels 30
London 30
Guangzhou 29
Bologna 28
Jakarta 26
Chicago 24
Philadelphia 24
Washington 23
Des Moines 21
Lanzhou 20
Verona 20
Napoli 19
Taizhou 19
Tappahannock 19
Torino 18
Indiana 17
Naples 17
Hefei 16
Brno 15
Hangzhou 15
Bari 14
Dong Ket 14
Helsinki 14
Camerino 13
Padova 13
Catania 12
Ferrara di Monte Baldo 12
Haikou 12
Redmond 12
Augusta 11
Kilburn 11
Livorno 11
Cagliari 9
Meppel 9
Olomouc 9
Otura 9
Bergamo 7
Caserta 7
Munich 7
Reggio Emilia 7
Reggio Nell'emilia 7
Ardabil 6
Aversa 6
Foggia 6
Genoa 6
Hounslow 6
Monmouth Junction 6
Montebelluna 6
Palermo 6
Salerno 6
Changchun 5
Dallas 5
Edinburgh 5
Totale 19.554
Nome #
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.123
PRIN 2007 Coordinatore Nazionale del progetto Dott. Stefania Gessi- Il recettore A3 dell’adenosina: un potenziale bersaglio per la diagnosi, prognosi e terapia del cancro colorettale 253
A glance at adenosine receptors: Novel target for antitumor therapy 193
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 187
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 185
The A3 adenosine receptor: history and perspectives 160
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 153
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 152
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 151
Pharmacology of Adenosine Receptors: The State of the Art 148
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 147
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 146
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 145
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 142
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 141
Pathological overproduction: the bad side of adenosine 140
Adenosine receptors and human melanoma 136
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 133
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 132
Adenosine receptor targeting in health and disease 131
Therapeutic potential of adenosine receptor antagonists and agonists 131
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 128
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 128
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 127
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 126
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 124
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 123
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 120
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 120
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 120
Adenosine receptors and cancer 120
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 120
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 119
null 118
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 117
Synthesis and preliminary biological evaluation of novel N-substituted 1-amino-3-[1-methyl(phenyl)-1H-indazol-4-yloxy]-propan-2-ols interesting as potential antiarrhythmic, local anaesthetic and analgesic agents 117
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 117
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 117
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 117
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 117
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 116
Binding thermodynamics at A1 and A2A adenosine receptors 115
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 115
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour. 114
A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT(1A) receptor ligands 114
null 113
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 113
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 113
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 113
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 113
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 113
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 112
null 112
New potent and selective human adenosine A3 receptor antagonists. 112
The A3 adenosine receptor: an enigmatic player in cell biology. 111
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 111
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 111
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 110
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 110
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 110
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 109
Agonists and antagonists: Molecular mechanisms and therapeutic applications 109
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 108
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects. 108
Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands 108
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 107
null 107
Adenosine receptors in health and disease 107
A(2A) adenosine receptors in human peripheral blood cells 106
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 106
null 106
Novel selective antagonist radioligands for the pharmacological study of A2B adenosine receptors 105
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 105
Adenosine and lymphocyte regulation 105
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 104
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line 104
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 104
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. 104
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 104
van't Hoff Based Thermodynamics 104
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 103
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 103
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 103
The P2X7 receptor as a therapeutic target. 102
null 102
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 102
null 102
Synthesis, molecular modeling and opioid receptor affinity of 9,10-diazatricyclo[4.2.1.1 2,5]decanes and 2,7-diazatricyclo[4.4.0.0 3,8]decanes structurally related to 3,8-diazabicyclo[3.2.1]octanes 101
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 101
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 101
Adenosine receptors and cancer 101
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 100
Adenosine A2A receptors in human circulating blood elements 100
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 100
Synthesis and preliminary biological evaluation of [H-3]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A(3) adenosine receptors 99
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 99
Binding thermodynamics of 5-HT(1A) receptor ligands 99
Benzocondensed derivatives as rigid analogues of the μ-opioid agonist 3(8)-cinnamyl-8(3)-propionyl-3,8-diazabicyclo[3,2,1]octanes: Synthesis, modeling, and affinity 98
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 98
3H SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes 98
Totale 12.907
Categoria #
all - tutte 104.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.824
Totale 110.554


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.495 1.001 158 143 746 318 659 484 550 414 647 281 94
2020/20214.151 397 431 173 487 220 445 145 471 76 563 511 232
2021/20223.182 68 328 207 157 141 135 118 174 113 266 459 1.016
2022/20233.721 360 289 119 500 617 497 183 308 461 43 202 142
2023/20242.024 181 253 100 48 230 217 101 133 51 96 100 514
2024/202575 75 0 0 0 0 0 0 0 0 0 0 0
Totale 28.224